Literature DB >> 1735158

Evidence of genetic heterogeneity in five kindreds with familial hypertrophic cardiomyopathy.

N D Epstein1, L Fananapazir, H J Lin, J Mulvihill, R White, J M Lalouel, R P Lifton, A W Nienhuis, M Leppert.   

Abstract

BACKGROUND: Recently, two families with hypertrophic cardiomyopathy have been shown to have mutations in the cardiac beta-myosin heavy chain gene (beta-MHC) located on the long arm of chromosome 14. METHODS AND
RESULTS: We have performed linkage analysis of five newly ascertained pedigrees with more than 50 chromosomal markers detecting polymorphisms. Our findings confirm the linkage to beta-MHC gene locus on chromosome 14 in one family (LOD score, 4.50) and suggest linkage to the same gene in another kindred. Chromosome 14 markers were not linked to the disease gene in the other three kindreds, however, and a test for genetic heterogeneity was statistically significant. Moreover, markers for the beta-MHC gene identified affected individuals who were recombinants with respect to this gene and the disease phenotype in these three kindreds.
CONCLUSIONS: These results provide conclusive evidence that hypertrophic cardiomyopathy in separate families is caused by mutations in disease genes at two or more locations in the genome.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1735158     DOI: 10.1161/01.cir.85.2.635

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  17 in total

1.  Expression of a missense mutation in the messenger RNA for beta-myosin heavy chain in myocardial tissue in hypertrophic cardiomyopathy.

Authors:  M B Perryman; Q T Yu; A J Marian; A Mares; G Czernuszewicz; J Ifegwu; R Hill; R Roberts
Journal:  J Clin Invest       Date:  1992-07       Impact factor: 14.808

2.  Malignant familial hypertrophic cardiomyopathy in a family with a 453Arg-->Cys mutation in the beta-myosin heavy chain gene: coexistence of sudden death and end-stage heart failure.

Authors:  Y L Ko; J J Chen; T K Tang; J J Cheng; S Y Lin; Y C Liou; P Kuan; C W Wu; W P Lien; C C Liew
Journal:  Hum Genet       Date:  1996-05       Impact factor: 4.132

3.  The in vitro motility activity of beta-cardiac myosin depends on the nature of the beta-myosin heavy chain gene mutation in hypertrophic cardiomyopathy.

Authors:  G Cuda; L Fananapazir; N D Epstein; J R Sellers
Journal:  J Muscle Res Cell Motil       Date:  1997-06       Impact factor: 2.698

4.  Hypertrophic cardiomyopathy.

Authors:  M Burch
Journal:  Arch Dis Child       Date:  1994-12       Impact factor: 3.791

5.  A trinucleotide repeat combination polymorphism in the cardiac alpha myosin heavy chain (MYH6) gene.

Authors:  M H van den Berg; H Meijer; J P Geraedts
Journal:  Hum Genet       Date:  1995-06       Impact factor: 4.132

6.  Screening for hypertrophic cardiomyopathy.

Authors:  A L Clark; A J Coats
Journal:  BMJ       Date:  1993-02-13

7.  Familial hypertrophic cardiomyopathy. Microsatellite haplotyping and identification of a hot spot for mutations in the beta-myosin heavy chain gene.

Authors:  E Dausse; M Komajda; L Fetler; O Dubourg; C Dufour; L Carrier; C Wisnewsky; J Bercovici; C Hengstenberg; S al-Mahdawi
Journal:  J Clin Invest       Date:  1993-12       Impact factor: 14.808

Review 8.  Molecular basis of hypertrophic and dilated cardiomyopathy.

Authors:  A J Marian; R Roberts
Journal:  Tex Heart Inst J       Date:  1994

9.  Missense mutations in the beta-myosin heavy-chain gene cause central core disease in hypertrophic cardiomyopathy.

Authors:  L Fananapazir; M C Dalakas; F Cyran; G Cohn; N D Epstein
Journal:  Proc Natl Acad Sci U S A       Date:  1993-05-01       Impact factor: 11.205

10.  Mapping the locus for familial hypertrophic cardiomyopathy to chromosome 11 in a family with a case of apical hypertrophic cardiomyopathy of the Japanese type.

Authors:  Y L Ko; J J Chen; T K Tang; M S Teng; S Y Lin; P Kuan; C W Wu; W P Lien; C C Liew
Journal:  Hum Genet       Date:  1996-04       Impact factor: 4.132

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.